Healthcare

May 31, 2016

1

Draft Health Bill: Several deterrent articles to fight against tobacco

ALGIERS- Draft health bill, which will be tables to the government, includes several deterrent articles prohibiting tobacco promotion and its consumption in public places in Algeria.

The consumption, promotion and tobacco manufacturing are subject to severe restrictions in the bill. Its provisions discourage tobacco consumption which is the cause of several cancers.

The"...

Continue Reading >

May 30, 2016

2

Samsung Bioepis Becomes First to Obtain European Commission Approval for Second Anti-TNF-α Biosimilar with Flixabi®

  • Samsung Bioepis solidifies industry leadership in biosimilars by becoming the first company to bring a second anti-TNF-α biosimilar to market
  • Flixabi® is Samsung Bioepis’ second anti-TNF-α biosimilar to receive European Commission approval, following Benepali®, the first-ever etanercept biosimilar in Europe

Samsung Bioepis Co., Ltd. today announced the European Commission’s (EC) approval of Flixabi® – a biosimilar version of Remicade®(infliximab), also known as"...

Continue Reading >

May 30, 2016

3

DM Foundation Announces Winners of Aster Media Awards 2016

Sajila Saseendran, Senior Reporter at Khaleej Times and Anand Raj, Features Editor at Gulf News, have been declared joint winners in the International-GCC category of the Aster Media Awards, instituted by the DM Foundation, the philanthropic arm of leading GCC and India private healthcare service provider, Aster DM Healthcare.


Saseendran’s"...

Continue Reading >

May 29, 2016

4

Private equity eyes North Africa healthcare

Private equity groups are increasingly eyeing opportunities in North Africa’s healthcare market, attracted by expanding populations spending more out of their own pockets on private medical services in countries where state provision is inadequate or underfunded.


The UAE-based Abraaj, which has $9bn of assets under management, has teamed up this year with three development"...

Continue Reading >

May 29, 2016

5

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) as Consolidation Treatment in Post-Transplant Hodgkin Lymphoma

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the extension of the current conditional approval of ADCETRIS® (brentuximab vedotin) and recommended its approval for the treatment of adult patients with CD30+ Hodgkin lymphoma at increased risk of relapse or progression following autologous stem cell transplantation (ASCT). On average 50 percent of Hodgkin lymphoma patients"...

Continue Reading >

May 28, 2016

6

Takeda Provides Update on EU Marketing Authorization Application for NINLARO® (ixazomib) in Relapsed/Refractory Multiple Myeloma

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a negative opinion, recommending against the authorization of NINLARO® (ixazomib) capsules, an oral proteasome inhibitor"...

Continue Reading >

May 26, 2016

7

Masimo to Showcase Next Generation SedLine® Brain Function Monitor at 2016 Euroanaesthesia Congress

Masimo (NASDAQ: MASI) announced today the CE mark and scheduled full market release of Next Generation SedLine® Brain Function Monitoring technology at the European Society of Anaesthesiology’s (ESA) 2016 Euroanaesthesia Congress in London, England.


Next Generation SedLine enhances how Masimo’s processed EEG parameter, the Patient State Index (PSI), responds in challenging situations, addressing many of the concerns raised with quantitative EEG while bolstering"......

Continue Reading >

May 26, 2016

8

3 out of 4 people with symptomatic asthma report reduced productivity at work

  • New survey shows that 3 out of 4 people with symptomatic asthma claim that their symptoms affected their productivity while working1
  • On average people with asthma symptoms missed 3 hours of work over a one week period despite taking maintenance treatment1

Not for distribution to UK/US/Canadian media

Results were released today by Boehringer Ingelheim from an international survey, providing new insight into the negative impact"...

Continue Reading >

May 25, 2016

9

Algeria supports Africa's candidate for WHO Director-General position

Algeria supports Africa's candidate for the position of director general of the World Health Organization (WHO), said Tuesday in Geneva, Switzerland, Minister of Health, Population and Hospital Reform Abdelmalek Boudiaf.


"Algeria, as coordinator of the African Group at the WHO and the African Union (AU), decided to support Africa's candidate, Ethiopian Adhanom Tedros,""...

Continue Reading >

May 24, 2016

10

Africa counts on Algeria to assist, help continent combat epidemics

GENEVA- Africa counts a lot on Algeria's expertise to assist and help countries of the continent to combat epidemics and other diseases, said Monday in Geneva the World Health Organization (WHO)'s Regional Director for Africa, Matshidiso Moeti.

"Algeria is among the most developed African countries in the field of health and we count a lot on its expertise to help countries of the continent to combat epidemics and other diseases," Moeti told the"...

Continue Reading >
 

Forex Market Video